The Clorox Company (CLX) 10-Year Financial Performance & Capital Metrics

CLX • • Industrial / General

Consumer DefensiveHousehold ProductsHousehold Cleaning & MaintenanceHousehold Cleaning Brands

AboutThe Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States. The Household segment provides cat litter products under the Fresh Step and Scoop Away brands; bags and wraps under the Glad brand; and grilling products under the Kingsford brand in the United States. The Lifestyle segment offers dressings, dips, seasonings, and sauces primarily under the Hidden Valley brand; natural personal care products under the Burt's Bees brand; and water-filtration products under the Brita brand in the United States. The International segment provides laundry additives; home care products; water-filtration systems; digestive health products; grilling products; cat litter products; food products; bags and wraps; natural personal care products; and professional cleaning and disinfecting products internationally primarily under the Clorox, Ayudin, Clorinda, Poett, Pine-Sol, Glad, Brita, RenewLife, Ever Clean and Burt's Bees brands. The Clorox Company sells its products primarily through mass retailers; grocery outlets; warehouse clubs; dollar stores; home hardware centers; drug, pet and military stores; third-party and owned e-commerce channels; and distributors, as well as a direct sales force The company was founded in 1913 and is headquartered in Oakland, California.Show more

Revenue $7.1B +0.2%
EBITDA $1.4B +21.5%
Net Income $810M +189.3%
EPS (Diluted) 6.52 +189.8%
Gross Margin 44.96% +5.4%
EBITDA Margin 19.68% +21.3%
Operating Margin 16.6% +28.5%
Net Margin 11.4% +188.8%
ROE 166.32% +161.4%
ROIC 27.68% +23.7%
Debt/Equity 5.98 +1.3%
Interest Coverage 11.67 +31.3%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Dividend Aristocrat: 26 years of consecutive increases
✓Excellent 3Y average ROE of 85.5%
✓Strong Piotroski F-Score: 7/9
✓High quality earnings: Operating CF exceeds net income
✓Healthy dividend yield of 4.4%
✓Efficient asset utilization: 1.3x turnover

✗Weaknesses

✗High debt to equity ratio of 6.0x
✗Trading more than 30% below 52-week high
✗Expensive at 28.7x book value

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y2.31%

5Y1.11%

3Y-0.01%

TTM-9.35%

Profit (Net Income) CAGR

10Y3.4%

5Y-2.91%

3Y20.58%

TTM121.57%

EPS CAGR

10Y4.08%

5Y-2.37%

3Y20.46%

TTM122.73%

ROCE

10Y Avg28.53%

5Y Avg23.11%

3Y Avg24.06%

Latest30.16%

Peer Comparison

Household Cleaning Brands

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
CHDChurch & Dwight Co., Inc.	21.71B	90.43	38.16	4.08%	12.74%	18.53%	4.5%	0.55
CLXThe Clorox Company	13.57B	111.23	17.06	0.16%	11.68%	5.73%	5.61%	5.98

Profit & Loss

	Jun 2016	Jun 2017	Jun 2018	Jun 2019	Jun 2020	Jun 2021	Jun 2022	Jun 2023	Jun 2024	Jun 2025
Sales/Revenue+	5.76B	5.97B	6.12B	6.21B	6.72B	7.34B	7.11B	7.39B	7.09B	7.1B
Revenue Growth %	0.02%	0.04%	0.03%	0.01%	0.08%	0.09%	-0.03%	0.04%	-0.04%	0%
Cost of Goods Sold+	3.16B	3.31B	3.46B	3.5B	3.67B	4.16B	4.62B	4.52B	4.07B	3.91B
COGS % of Revenue	0.55%	0.55%	0.56%	0.56%	0.55%	0.57%	0.65%	0.61%	0.57%	0.55%
Gross Profit+	2.6B	2.67B	2.66B	2.71B	3.05B	3.18B	2.49B	2.87B	3.02B	3.19B
Gross Margin %	0.45%	0.45%	0.44%	0.44%	0.45%	0.43%	0.35%	0.39%	0.43%	0.45%
Gross Profit Growth %	0.06%	0.02%	-0%	0.02%	0.13%	0.04%	-0.22%	0.15%	0.05%	0.06%
Operating Expenses+	1.53B	1.54B	1.54B	1.6B	1.79B	1.94B	1.79B	2.04B	2.11B	2.02B
OpEx % of Revenue	0.27%	0.26%	0.25%	0.26%	0.27%	0.26%	0.25%	0.28%	0.3%	0.28%
Selling, General & Admin	1.39B	1.41B	1.41B	1.47B	1.64B	1.79B	1.66B	1.91B	1.98B	1.89B
SG&A % of Revenue	0.24%	0.24%	0.23%	0.24%	0.24%	0.24%	0.23%	0.26%	0.28%	0.27%
Research & Development	141M	135M	132M	136M	145M	149M	132M	138M	126M	121M
R&D % of Revenue	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%
Other Operating Expenses	0	0	0	0	0	0	0	0	0	0
Operating Income+	1.07B	1.12B	1.13B	1.11B	1.26B	1.24B	696M	827M	916M	1.18B
Operating Margin %	0.19%	0.19%	0.18%	0.18%	0.19%	0.17%	0.1%	0.11%	0.13%	0.17%
Operating Income Growth %	0.07%	0.05%	0%	-0.02%	0.14%	-0.02%	-0.44%	0.19%	0.11%	0.29%
EBITDA+	1.23B	1.28B	1.29B	1.29B	1.44B	1.45B	920M	1.06B	1.15B	1.4B
EBITDA Margin %	0.21%	0.22%	0.21%	0.21%	0.21%	0.2%	0.13%	0.14%	0.16%	0.2%
EBITDA Growth %	0.05%	0.04%	0.01%	-0%	0.12%	0%	-0.36%	0.16%	0.08%	0.21%
D&A (Non-Cash Add-back)	165M	163M	167M	182M	179M	210M	224M	236M	235M	219M
EBIT	1.06B	1.11B	1.13B	1.11B	1.28B	993M	704M	341M	501M	1.18B
Net Interest Income+	-77M	-78M	-73M	-88M	-91M	-88M	-92M	-87M	-80M	-92M
Interest Income	5M	4M	6M	3M	2M	5M	5M	16M	23M	9M
Interest Expense	82M	82M	79M	91M	93M	93M	97M	103M	103M	101M
Other Income/Expense	-85M	-89M	-71M	-83M	-80M	-338M	-89M	-589M	-518M	-101M
Pretax Income+	983M	1.03B	1.05B	1.02B	1.19B	900M	607M	238M	398M	1.08B
Pretax Margin %	0.17%	0.17%	0.17%	0.16%	0.18%	0.12%	0.09%	0.03%	0.06%	0.15%
Income Tax+	335M	330M	231M	204M	246M	181M	136M	77M	106M	254M
Effective Tax Rate %	0.66%	0.68%	0.78%	0.8%	0.79%	0.79%	0.76%	0.63%	0.7%	0.75%
Net Income+	648M	701M	823M	820M	939M	710M	462M	149M	280M	810M
Net Margin %	0.11%	0.12%	0.13%	0.13%	0.14%	0.1%	0.07%	0.02%	0.04%	0.11%
Net Income Growth %	0.12%	0.08%	0.17%	-0%	0.15%	-0.24%	-0.35%	-0.68%	0.88%	1.89%
Net Income (Continuing)	648M	703M	823M	820M	939M	719M	471M	161M	292M	824M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	181M	173M	168M	164M	161M
EPS (Diluted)+	4.92	5.33	6.25	6.32	7.35	5.58	3.73	1.20	2.25	6.52
EPS Growth %	0.13%	0.08%	0.17%	0.01%	0.16%	-0.24%	-0.33%	-0.68%	0.88%	1.9%
EPS (Basic)	5.01	5.43	6.37	6.42	7.46	5.65	3.75	1.21	2.25	6.56
Diluted Shares Outstanding	131.72M	131.57M	131.58M	129.79M	127.67M	127.3M	123.91M	124.18M	124.8M	124.29M
Basic Shares Outstanding	129.47M	128.95M	129.29M	127.73M	125.83M	125.57M	123.11M	123.59M	124.17M	123.53M
Dividend Payout Ratio	0.61%	0.59%	0.55%	0.6%	0.57%	0.79%	1.24%	3.91%	2.13%	0.74%

Balance Sheet

	Jun 2016	Jun 2017	Jun 2018	Jun 2019	Jun 2020	Jun 2021	Jun 2022	Jun 2023	Jun 2024	Jun 2025
Total Current Assets+	1.49B	1.51B	1.31B	1.3B	2.02B	1.83B	1.73B	1.83B	1.62B	1.61B
Cash & Short-Term Investments	401M	418M	131M	111M	871M	319M	183M	367M	202M	167M
Cash Only	401M	418M	131M	111M	871M	319M	183M	367M	202M	167M
Short-Term Investments	0	0	0	0	0	0	0	0	0	0
Accounts Receivable	569M	565M	600M	631M	648M	604M	681M	688M	695M	821M
Days Sales Outstanding	36.05	34.53	35.76	37.06	35.19	30.03	34.97	33.99	35.76	42.18
Inventory	443M	459M	506M	512M	454M	752M	755M	696M	637M	523M
Days Inventory Outstanding	51.19	50.66	53.38	53.35	45.19	65.98	59.7	56.23	57.15	48.82
Other Current Assets	0	0	0	0	0	0	0	77M	88M	97M
Total Non-Current Assets+	3.03B	3.06B	3.75B	3.81B	4.19B	4.5B	4.43B	4.12B	4.13B	3.95B
Property, Plant & Equipment	906M	931M	996M	1.03B	1.39B	1.63B	1.68B	1.69B	1.68B	1.6B
Fixed Asset Turnover	6.36x	6.42x	6.15x	6.01x	4.82x	4.49x	4.24x	4.37x	4.23x	4.44x
Goodwill	1.2B	1.2B	1.6B	1.59B	1.58B	1.57B	1.56B	1.25B	1.23B	1.23B
Intangible Assets	735M	722M	929M	912M	894M	918M	884M	712M	681M	566M
Long-Term Investments	0	0	0	0	0	0	0	0	0	0
Other Non-Current Assets	187M	210M	222M	274M	328M	378M	315M	462M	545M	558M
Total Assets+	4.52B	4.57B	5.06B	5.12B	6.21B	6.33B	6.16B	5.95B	5.75B	5.56B
Asset Turnover	1.28x	1.31x	1.21x	1.21x	1.08x	1.16x	1.15x	1.24x	1.23x	1.28x
Asset Growth %	0.09%	0.01%	0.11%	0.01%	0.21%	0.02%	-0.03%	-0.03%	-0.03%	-0.03%
Total Current Liabilities+	1.56B	1.81B	1.2B	1.44B	1.42B	2.06B	1.78B	1.92B	1.57B	1.92B
Accounts Payable	490M	501M	507M	507M	575M	930M	960M	1.02B	950M	838M
Days Payables Outstanding	56.62	55.3	53.48	52.83	57.23	81.6	75.91	82.48	85.24	78.23
Short-Term Debt	523M	804M	199M	396M	0	300M	237M	50M	4M	4M
Deferred Revenue (Current)	0	0	0	0	0	0	0	0	0	0
Other Current Liabilities	192M	162M	154M	158M	288M	219M	176M	262M	190M	179M
Current Ratio	0.95x	0.84x	1.09x	0.91x	1.42x	0.89x	0.97x	0.95x	1.03x	0.84x
Quick Ratio	0.67x	0.58x	0.67x	0.55x	1.10x	0.52x	0.54x	0.59x	0.63x	0.57x
Cash Conversion Cycle	30.62	29.89	35.66	37.58	23.15	14.41	18.76	7.73	7.68	12.78
Total Non-Current Liabilities+	2.66B	2.22B	3.13B	3.12B	3.89B	3.69B	3.65B	3.64B	3.69B	3.16B
Long-Term Debt	1.79B	1.39B	2.28B	2.29B	2.78B	2.48B	2.47B	2.48B	2.48B	2.48B
Capital Lease Obligations	0	0	0	0	278M	301M	314M	310M	334M	305M
Deferred Tax Liabilities	82M	61M	72M	50M	62M	67M	66M	28M	22M	20M
Other Non-Current Liabilities	784M	770M	778M	780M	767M	834M	791M	825M	848M	351M
Total Liabilities	4.22B	4.03B	4.33B	4.56B	5.3B	5.74B	5.43B	5.56B	5.26B	5.08B
Total Debt+	2.31B	2.19B	2.48B	2.68B	3.12B	3.17B	3.1B	2.92B	2.9B	2.88B
Net Debt	1.91B	1.78B	2.35B	2.57B	2.25B	2.85B	2.92B	2.56B	2.7B	2.71B
Debt / Equity	7.78x	4.05x	3.42x	4.80x	3.44x	5.35x	4.26x	7.54x	5.90x	5.98x
Debt / EBITDA	1.88x	1.71x	1.92x	2.08x	2.16x	2.19x	3.37x	2.75x	2.52x	2.06x
Net Debt / EBITDA	1.55x	1.38x	1.82x	2.00x	1.56x	1.97x	3.17x	2.41x	2.35x	1.94x
Interest Coverage	13.02x	13.68x	14.24x	12.16x	13.60x	13.31x	7.18x	8.03x	8.89x	11.67x
Total Equity+	297M	542M	726M	559M	908M	592M	729M	388M	492M	482M
Equity Growth %	1.52%	0.82%	0.34%	-0.23%	0.62%	-0.35%	0.23%	-0.47%	0.27%	-0.02%
Book Value per Share	2.25	4.12	5.52	4.31	7.11	4.65	5.88	3.12	3.94	3.88
Total Shareholders' Equity	297M	542M	726M	559M	908M	411M	556M	220M	328M	321M
Common Stock	159M	159M	159M	159M	159M	131M	131M	131M	131M	131M
Retained Earnings	2.16B	2.44B	2.8B	3.15B	3.57B	1.04B	1.05B	583M	250M	432M
Treasury Stock	-2.32B	-2.44B	-2.66B	-3.19B	-3.31B	-1.4B	-1.35B	-1.25B	-1.19B	-1.4B
Accumulated OCI	-570M	-543M	-547M	-602M	-640M	-546M	-479M	-493M	-155M	-157M
Minority Interest	0	0	0	0	0	181M	173M	168M	164M	161M

Cash Flow

	Jun 2016	Jun 2017	Jun 2018	Jun 2019	Jun 2020	Jun 2021	Jun 2022	Jun 2023	Jun 2024	Jun 2025
Cash from Operations+	778M	868M	974M	992M	1.55B	1.28B	786M	1.16B	695M	981M
Operating CF Margin %	0.14%	0.15%	0.16%	0.16%	0.23%	0.17%	0.11%	0.16%	0.1%	0.14%
Operating CF Growth %	-0.11%	0.12%	0.12%	0.02%	0.56%	-0.17%	-0.38%	0.47%	-0.4%	0.41%
Net Income	648M	703M	823M	820M	939M	719M	471M	161M	292M	824M
Depreciation & Amortization	165M	163M	166M	180M	180M	211M	224M	236M	235M	219M
Stock-Based Compensation	45M	51M	53M	43M	50M	50M	52M	73M	74M	81M
Deferred Taxes	5M	-35M	-23M	-20M	-2M	-32M	5M	-149M	-100M	-18M
Other Non-Cash Items	11M	30M	44M	-29M	30M	339M	133M	483M	435M	86M
Working Capital Changes	-96M	-47M	-88M	-2M	349M	-11M	-99M	354M	-241M	-211M
Change in Receivables	-52M	-1M	-24M	-32M	-27M	82M	-84M	-13M	-34M	-145M
Change in Inventory	-45M	-19M	-21M	-7M	50M	-282M	-18M	58M	55M	63M
Change in Payables	57M	-34M	-47M	17M	291M	311M	-47M	157M	-140M	-124M
Cash from Investing+	-430M	-205M	-859M	-196M	-252M	-452M	-229M	-223M	-175M	-94M
Capital Expenditures	-172M	-231M	-194M	-206M	-254M	-331M	-251M	-228M	-212M	-220M
CapEx % of Revenue	0.03%	0.04%	0.03%	0.03%	0.04%	0.05%	0.04%	0.03%	0.03%	0.03%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	32M	26M	16M	10M	2M	-36M	22M	5M	20M	-2M
Cash from Financing+	-316M	-645M	-399M	-815M	-523M	-1.39B	-689M	-753M	-655M	-924M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	-398M	-412M	-450M	-490M	-533M	-558M	-571M	-583M	-595M	-602M
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	0	0	0	0	0	-31M	-15M	-15M	-16M	-16M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	606M	637M	780M	786M	1.29B	945M	535M	930M	483M	761M
FCF Margin %	0.11%	0.11%	0.13%	0.13%	0.19%	0.13%	0.08%	0.13%	0.07%	0.11%
FCF Growth %	-0.19%	0.05%	0.22%	0.01%	0.64%	-0.27%	-0.43%	0.74%	-0.48%	0.58%
FCF per Share	4.60	4.84	5.93	6.06	10.12	7.42	4.32	7.49	3.87	6.12
FCF Conversion (FCF/Net Income)	1.20x	1.24x	1.18x	1.21x	1.65x	1.80x	1.70x	7.77x	2.48x	1.21x
Interest Paid	79M	78M	75M	87M	89M	89M	89M	99M	102M	97M
Taxes Paid	323M	347M	245M	207M	241M	303M	100M	73M	347M	264M

Key Ratios

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Return on Equity (ROE)	312.29%	167.1%	129.81%	127.63%	128.02%	94.67%	69.95%	26.68%	63.64%	166.32%
Return on Invested Capital (ROIC)	38.74%	37.18%	31.27%	26.74%	30.17%	28.14%	14.73%	18.81%	22.39%	27.68%
Gross Margin	45.17%	44.63%	43.5%	43.63%	45.44%	43.33%	35.05%	38.86%	42.65%	44.96%
Net Margin	11.25%	11.74%	13.44%	13.2%	13.97%	9.67%	6.5%	2.02%	3.95%	11.4%
Debt / Equity	7.78x	4.05x	3.42x	4.80x	3.44x	5.35x	4.26x	7.54x	5.90x	5.98x
Interest Coverage	13.02x	13.68x	14.24x	12.16x	13.60x	13.31x	7.18x	8.03x	8.89x	11.67x
FCF Conversion	1.20x	1.24x	1.18x	1.21x	1.65x	1.80x	1.70x	7.77x	2.48x	1.21x
Revenue Growth	1.87%	3.68%	2.53%	1.47%	8.16%	9.22%	-3.19%	3.97%	-4.01%	0.16%

Revenue by Segment

	2015	2017	2018	2019	2020	2021	2022	2023	2024	2025
Health and Wellness	-	-	-	-	2.75B	2.98B	2.69B	2.53B	2.48B	2.7B
Health and Wellness Growth	-	-	-	-	-	8.40%	-9.73%	-5.87%	-1.86%	8.53%
Household	1.79B	1.96B	1.96B	1.87B	1.79B	1.98B	1.98B	2.1B	1.95B	2B
Household Growth	-	9.31%	-0.10%	-4.54%	-4.01%	10.36%	0.15%	5.75%	-7.05%	2.62%
Lifestyle	950M	1B	1.08B	1.26B	1.15B	1.22B	1.25B	1.34B	1.27B	1.3B
Lifestyle Growth	-	5.26%	7.70%	17.46%	-8.77%	5.55%	2.87%	6.78%	-4.71%	2.20%
International	1.09B	1.01B	1.03B	970M	1.02B	1.16B	1.18B	1.18B	1.16B	1.06B
International Growth	-	-7.08%	1.78%	-5.64%	5.46%	13.59%	1.55%	0.08%	-1.61%	-8.35%
Cleaning	1.82B	2B	2.06B	2.11B	-	-	-	-	-	-
Cleaning Growth	-	9.76%	2.90%	2.38%	-	-	-	-	-	-

Revenue by Geography

	2015	2017	2018	2019	2020	2021	2022	2023	2024	2025
UNITED STATES	4.61B	5B	5.13B	5.28B	5.72B	6.21B	5.95B	6.24B	5.96B	6.08B
UNITED STATES Growth	-	8.51%	2.68%	2.84%	8.41%	8.42%	-4.12%	4.81%	-4.51%	2.08%
Foreign	-	-	-	-	996M	-	-	-	-	1.02B
Foreign Growth	-	-	-	-	-	-	-	-	-	-
International	1.05B	972M	989M	933M	-	1.13B	1.16B	1.15B	-	-
International Growth	-	-7.07%	1.75%	-5.66%	-	-	1.94%	-0.35%	-	-

Frequently Asked Questions

Valuation & Price

The Clorox Company (CLX) has a price-to-earnings (P/E) ratio of 17.1x. This is roughly in line with market averages.

Growth & Financials

The Clorox Company (CLX) reported $6.77B in revenue for fiscal year 2025. This represents a 24% increase from $5.47B in 2012.

The Clorox Company (CLX) grew revenue by 0.2% over the past year. Growth has been modest.

Yes, The Clorox Company (CLX) is profitable, generating $791.0M in net income for fiscal year 2025 (11.4% net margin).

Dividend & Returns

Yes, The Clorox Company (CLX) pays a dividend with a yield of 4.35%. This makes it attractive for income-focused investors.

The Clorox Company (CLX) has a return on equity (ROE) of 166.3%. This is excellent, indicating efficient use of shareholder capital.

The Clorox Company (CLX) generated $636.0M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

US Stock Screener

...